Most recent by J. Nicholas Bodor, MD, PhD, MPH
VIDEO: Improving immune checkpoint inhibitor use in EGFR-mutated lung cancer
In this video, J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, highlights current challenges within the EGFR-mutated lung cancer space.
VIDEO: Expert offers advice for residents seeing patients with EGFR-mutated lung cancer
In this video, J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, offers advice to new residents seeing patients with EGFR-mutated lung cancer.
VIDEO: Monitoring for brain metastases key in patients with recurrent EGFR-mutated lung cancer
J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, spoke with Healio about monitoring patients with recurrent EGFR-mutated lung cancer.
VIDEO: Collective understanding of biomarker testing important for EGFR-mutated lung cancer
In this video, J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, highlights important takeaways for interventional pulmonologists and other providers who may see patients with EGFR-mutated lung cancer.
VIDEO: Future use of antibody-drug conjugates in EGFR-mutated lung cancer
In this video, J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, highlights potential treatments options coming to the EGFR-mutated lung cancer space.
VIDEO: ‘Flurry of activity’ in treatment space for EGFR-mutated lung cancer
In this video, J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, discusses the changing treatment landscape in EGFR-mutated lung cancer.